– Se ha administrado la primera dosis a los pacientes en el estudio clínico VIRAGE2 de Fase IIa, que evalúa la administración con mayor frecuencia de VCN-01 (zabilugene almadenorepvec), cuyo objetivo es mejorar los resultados del tratamiento en pacientes con adenocarcinoma ductal pancreático (PDAC) metastásico –
BEIJING, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The “YOU BRING CHARM TO THE WORLD - The 18th Global Chinese Awards” came to a close at the Phoenix Center in Beijing on the evening of August 12.
ST. LOUIS, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Latch, Inc., (DOOR) today released the following pursuant to an Order of the U.S. District Court for the Southern District of New York.
NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and May 27, 2026, inclusive (the “Class Period”), of the important August 25, 2026 lead plaintiff deadline.
Related Bing News Results Media OutReach Newswire Strengthens USA Distribution Network Sun, 26 Jul 2026 15:03:00 GMT The newswire guarantees online postings on USA Today and increases its guaranteed distribution on high-domain-rating local US news sites to empower AI visibility HONG KONG SAR - Media OutReach ...